Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Retinitis; Retinitis Pigmentosa; Syndrome; Usher Syndromes Phase 2 ClinicalTrials
Retinitis; Retinitis Pigmentosa Phase 2 ClinicalTrials
Retinitis; Retinitis Pigmentosa Phase 2 ClinicalTrials
CONTENTS